טוען...
The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-cell Lymphoma in the Era of CAR-T Cell Therapy
Abstract. For many years now and based on the results of the PARMA trial, relapsed Diffuse Large B-cell Lymphoma (DLBCL) is treated with salvage combination cytotoxic chemotherapy (most often platinum-based) followed by high dose myeloablative chemotherapy and autologous stem cell transplantation (a...
שמור ב:
Main Authors: | , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Wolters Kluwer
2019-12-01
|
סדרה: | HemaSphere |
גישה מקוונת: | http://journals.lww.com/10.1097/HS9.0000000000000295 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|